Nanologica
1.895
SEK
-1.56 %
NICA
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
1 following
-1.56%
+4.12%
-18.49%
-67.29%
-80.94%
-80.1%
-84.75%
-81.01%
-89.55%
Nanologica is a life science tools company that develops, manufactures and sells advanced consumables to pharmaceutical companies. Nanologica's silica-based products are specially designed for the purification of peptide drugs, such as insulin and GLP-1 analogs. Nanologica operates in a global niche market for medicines for the treatment of diabetes and obesity. Nanologica was founded in 2004 and has its headquarters in Södertälje.
Read moreMarket cap
167.44M SEK
Turnover
72.95K SEK
Revenue
1.44M
EBIT %
-4,858.33 %
P/E
-
Dividend yield-%
-
Financial calendar
7/2
2025
Annual report '24
17/4
2025
Interim report Q1'25
22/5
2025
General meeting '24
ShowingAll content types
Nanologica Receives Order on NLAB Saga® Valued at approx SEK 1,9 Million from Returning Customer in China
Antal aktier och röster i Nanologica AB (publ)
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools